CeriBell, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
CeriBell, Inc. (CBLL) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$513.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-24
- CeriBell, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was -$513.00K, a 239.78% decline from fiscal 2024.
- CeriBell, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $367.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | -$513.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $367.00K 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |